Altasciences Supports Metsera in Their Early Stage Clinical Trials for Obesity

Altasciences is proud to have supported Metsera, Inc., a clinical stage biopharmaceutical company, with nonclinical and early-stage clinical trials. This support includes a recent Phase I/II trial of MET-097i: an ultra-long-acting injectable amylin analog and fully biased GLP-1 receptor agonist.

In a trial conducted at our clinic, Metsera reported positive topline results. This study enabled Metsera to initiate a randomized 16-week Phase II trial of MET-097i, which could offer potential new treatment options for those affected by obesity. We also further supported Metsera with our proactive drug development solution, providing nonclinical, bioanalysis, CRO, and program management services for several other therapeutic candidates.

Altasciences Upholds Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services

A trusted drug development research partner for over 30 years, Altasciences remains committed to providing world-class bioanalytical services in support of the preclinical and clinical studies conducted at our cutting-edge facilities, as well as extensive standalone solutions to meet your diverse needs.

Our flexible bioanalytical services from discovery to Phase IV empower clients across every phase of research.

Let's Promote Your Project!

Interested in a custom press release, written by our experts, to feature the great research we do together? Email us to get started!

You may also be interested in:

• The Altascientist Issue No.42: Managing the Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development
• The Altascientist Issue No.41: Immunomodulation Assessments for Clinical Trials: Sophisticated Bioanalytical Approaches to Support Complex Modalities
• Case Study: GLP-1 RA: Overcoming Known Pharmacological Effects
• Case Study: GLP-1 RA: Rapid Clinical Phase I Study Execution
• Blog: 4 Essential Topics to Cover in Your First CRO Meeting
• Press Releases: View More

As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

Join Altasciences’ webinar to discover future trends and potential breakthroughs.

Speak with one of our experts to discuss your drug development program.

You may also be interested in these resources

• Scientific Journals: Managing the Complexities of GLP-1 Drug Development
• Fact Sheet: Metabolic Disorders Clinical Trials
• Case Study: Randomized Cross Over Efficacy Study Metabolic Disorder

Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services

We have been your trusted drug development research partner for over 30 years. We are committed to providing world-class bioanalytical services in support of the preclinical and clinical studies conducted at our cutting-edge facilities, as well as extensive standalone solutions to meet your diverse needs. Our flexible bioanalytical services from discovery to Phase IV empower our clients across every phase of research.

We recently launched the Unveiling the Invisible video campaign to showcase how our bioanalytical solutions provide critical insights that unveil the invisible and drive the creation of your innovative therapies.

RELATED RESOURCES

Our bioanalytical team excels in comprehensive bioanalytical services, including assay and method development, molecular biology, mass spectrometry, ligand binding assays, immunogenicity testing, biomarker analysis, flow cytometry services, and more, to support your journey from discovery through Phase IV.

Below are some resources that highlight our extensive knowledge, and wealth of bioanalytical experience.

• The Altascientist Issue 41: Immunomodulation Assessments for Clinical Trials—Sophisticated Bioanalytical Approaches to Support Complex Modalities
• eBook: Key Considerations for Nonclinical AAV Gene Therapy Development
• eBook: Key Biomarkers of Immunomodulation
• Scientific Research Article: A Novel Hybridization LC-MS/MS Methodology for Quantification of siRNA
• Scientific Research Article: A Validated Capillary Microsampling LC-MS Method for Quantification of ASOs in Mouse Serum
• Scientific Research Article: Microsampling in Pediatric Studies

The True Meaning of Moving in Unison

We value your time as much as you do. At Altasciences, we break down organizational silos, streamline project management, and promote effortless communication to provide you with exceptional value.

From preclinical studies to clinical trials, and from regulatory submissions to tackling operational challenges, we are dedicated to safely accelerating your journey from lead candidate selection to proof of concept and beyond using a seamless and integrated approach to drug development.

Let's get your project started! Speak with an expert today.

Connecting the Dots With Comprehensive CRO Solutions

When you CONNECT THE DOTS, you open a world of possibilities.

At Altasciences, we connect the dots, so you don’t have to. With you in mind, we establish a clear and consistent path from drug discovery to delivery—one solution seamlessly connecting to the next. All you have to do is reach out and get the conversation started.

Ready for a simpler drug development journey? Contact us today.

You may also be interested in these resources:

• Webpage: Clinical Research Support Services
• Video: Clinical Trial Site Identification, Selection, and Management
• Fact Sheet: Integrated Research Support Services

A Solution for Every Trial

Altasciences’ comprehensive clinical trial solutions, supported by over 25 years of CRO expertise, ensure a streamlined process—from study design to site identification, selection, and management.

Benefit from:

•   Global Reach: A network of 100+ active sites worldwide.
•   Therapeutic Expertise: Specialization in multiple therapeutic areas with access to a large pool of patient populations.
•   Innovative Approach: Hybrid model combining our clinical sites with partner sites for efficient recruitment.
•   Regulatory Excellence: Expert regulatory and scientific guidance throughout your project.
•   Seamless Collaboration: Close collaboration and communication, from site qualification to closure.
•   Project Precision: Comprehensive project plans and timelines for on-time, on-budget delivery.

Discover how Altasciences turns clinical trial challenges into solutions. View the insert.

You may also be interested in the following webpages:

      •   Clinical Trial Site Identification and Selection
      •   Clinical Trial Site Management

Getting to the Heart of Science

The privilege of following the development of a drug, from the preclinical phase to clinical trials, studying it, and then observing its integration into patient care is an extraordinary experience. Join Dr. Morelli, Chief Medical Officer at Altasciences, as he imparts insights on how his contribution to drug development is a profoundly gratifying journey.

​Watch the video.

The Secret to Accelerated
Drug Development

Our latest case study showcases how we started a Phase I study in just 3.5 weeks, 70% quicker than the industry’s 12-week standard. 

The secret to our success? Effective communication, strategic planning, optimal delegation of responsibilities, and removal of silos.

We aligned our internal team on all objectives, engaged in open dialogue with the sponsor throughout the study, and optimized project management by assigning two leads in two different time zones—expediting decision-making. This case study is your roadmap to faster drug development. 

Contact us to discuss how we can accelerate your study start-up timelines.